Rhythm Pharmaceuticals (RYTM) Capital Expenditures (2017 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Capital Expenditures of -$435000.0 for Q1 2026, down 326.47% year-over-year from $192077.9 in Q1 2025, and down 163.88% quarter-over-quarter from $681000.0 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Capital Expenditures (2017 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Capital Expenditures for 10 consecutive years, with -$435000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures fell 326.47% year-over-year to -$435000.0; the TTM figure through Mar 2026 stood at $64000.0 (down 94.14% YoY), while the FY2025 annual figure was $397000.0, changed N/A from the prior year.
- Capital Expenditures declined to -$435000.0 in Q1 2026 per RYTM's latest filing, from $681000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $5.2 million in Q3 2025 and bottomed at -$5.4 million in Q2 2025.
- Historically, Capital Expenditures has averaged -$83117.6 across 5 years, with a median of -$102000.0 in 2025.
- Annual changes were most pronounced in 2023 — Capital Expenditures sank 2136.67% — and 2024, when it jumped 78825.0%.
- Rhythm Pharmaceuticals' Capital Expenditures stood at -$4.6 million in 2022, then surged by 100.09% to $4000.0 in 2023, then surged by 78825.0% to $3.2 million in 2024, then slumped by 78.43% to $681000.0 in 2025, then slumped by 163.88% to -$435000.0 in 2026.
- Business Quant data shows RYTM's Capital Expenditures at -$435000.0 in Q1 2026, $681000.0 in Q4 2025, and $5.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -435,000.00 |
| Mar 31, 2026 | -435,000.00 |
| Dec 31, 2025 | 681,000.00 |
| Dec 31, 2025 | 681,000.00 |
| Sep 30, 2025 | 5.24 Mn |
| Sep 30, 2025 | 5.24 Mn |
| Jun 30, 2025 | -5.42 Mn |
| Jun 30, 2025 | -5.42 Mn |
| Mar 31, 2025 | -102,000.00 |
| Mar 31, 2025 | -102,000.00 |
| Dec 31, 2024 | 3.16 Mn |
| Dec 31, 2024 | 3.16 Mn |
| Sep 30, 2024 | -908,000.00 |
| Sep 30, 2024 | -908,000.00 |
| Jun 30, 2024 | -1.05 Mn |
| Jun 30, 2024 | -1.05 Mn |
| Mar 31, 2024 | -1.20 Mn |
| Mar 31, 2024 | -1.20 Mn |
| Dec 31, 2023 | 4,000.00 |
| Dec 31, 2023 | 4,000.00 |